Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway
暂无分享,去创建一个
M. Oshimura | I. Hisatome | Y. Shirayoshi | K. Morikawa | N. Ikeda | S. Nakano | S. Kawazoe | Kengo Miki | Masayuki Shibuya
[1] S. Shin,et al. Suppression of PTEN expression during aggregation with retinoic acid in P19 mouse embryonal carcinoma cells. , 2006, Biochemical and biophysical research communications.
[2] M. Okabe,et al. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells , 2006, Oncogene.
[3] H. Niwa,et al. Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. , 2006, Biochemical and biophysical research communications.
[4] J. Bastien,et al. The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells , 2006, Oncogene.
[5] Robert Lanza,et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres , 2006, Nature.
[6] L. Chin,et al. Nuclear cloning of embryonal carcinoma cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] Austin G Smith,et al. Self-renewal of teratocarcinoma and embryonic stem cells , 2004, Oncogene.
[8] N. Nakatsuji,et al. STAT3 Is Dispensable for Maintenance of Self‐Renewal in Nonhuman Primate Embryonic Stem Cells , 2004, Stem cells.
[9] Ana D. Lopez,et al. Maintenance of Pluripotency in Human Embryonic Stem Cells Is STAT3 Independent , 2004, Stem cells.
[10] P. Heinrich,et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.
[11] M. Murakami,et al. The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.
[12] J. Nichols,et al. Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.
[13] K. Mizuseki,et al. Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing Activity , 2000, Neuron.
[14] M. Katsuki,et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells , 1999, The EMBO journal.
[15] J. Nichols,et al. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. , 1998, Developmental biology.
[16] A. Smith,et al. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.
[17] T. Yamamoto,et al. Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell. , 1997, Endocrinology.
[18] Austin G Smith,et al. Essential function of LIF receptor in motor neurons , 1995, Nature.
[19] C. Stewart,et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor , 1992, Nature.
[20] L. Gudas,et al. Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. , 1991, Development.
[21] John K. Heath,et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides , 1988, Nature.
[22] Donald Metcalf,et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells , 1988, Nature.
[23] J. Rossant,et al. The developmental potential of a euploid male teratocarcinoma cell line after blastocyst injection. , 1982, Journal of embryology and experimental morphology.
[24] M. McBurney,et al. Isolation of male embryonal carcinoma cells and their chromosome replication patterns. , 1982, Developmental biology.
[25] G. Martin,et al. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Kaufman,et al. Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.
[27] A. Levine,et al. Alterations in the developmental potential of embryonal carcinoma cells in mixed aggregates of nullipotent and pluripotent cells , 1979, Cell.
[28] D. Solter,et al. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[29] B. Ephrussi,et al. Alkaline phosphatase activity in mouse teratoma. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[30] I. Klimanskaya,et al. Human embryonic stem cell lines derived from single blastomeres , 2006, Nature.
[31] P. Greengard,et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.
[32] D. Hilton,et al. Inhibition of differentiation in a murine F9 embryonal carcinoma cell subline by leukemia inhibitory factor (LIF). , 1992, Growth factors.
[33] J. D. Engel,et al. Developmental potential. , 1992, Genes & development.